期刊文献+

莫诺苷大鼠脑靶向分布研究 被引量:6

Study on Targeting Ddistribution of Morroniside in Rat Brain
原文传递
导出
摘要 目的:研究莫诺苷透过局造型脑缺血再灌注大鼠血脑屏障的能力。方法:建立大鼠在体脑血分布模型,探讨神经保护剂莫诺苷在正常组大鼠、假手术组大鼠和局灶性脑缺血再灌注模型组大鼠的脑靶向分布。采用线栓法制作局灶性脑缺血再灌注大鼠模型。造模成功后,3组大鼠尾静脉滴注莫诺苷溶液,待血药浓度达到稳态(55 min)后,取血和左右脑组织,采用已经建立的生物基质中莫诺苷浓度测定的LC-MS/MS方法测定大鼠血浆与脑组织中的莫诺苷浓度,并计算血脑分配系数(lg BB)。结果:莫诺苷在局造型脑缺血大鼠左右脑的lg BB分别为(1.36±0.44)和(2.26±0.13),但正常组大鼠和假手术组大鼠的lg BB值较低,药物透过该两组大鼠血脑屏障的能力较差,局造性脑缺血再灌注模型组大鼠的lg BB值明显高于正常组大鼠和假手术组大鼠。结论:较正常组大鼠和假手术组大鼠,莫诺苷可以明显透过局灶性脑缺血再灌注模型大鼠的血脑屏障。 Objective: The aim of this study was to investigate the steady-state brain-plasma concentration ratio of morroniside in focal cerebral ischemia-reperfusion model rats. Method: The in vivo rat model was established. The middle cerebral artery occlusion was induced by the intraluminal filament technique. The concentrations of morroniside in the plasma and brain of rats were determined from normal control group,shamoperated group and focal cerebral ischemia- reperfusion model group,and the blood brain partitioning(lg BB) of morroniside was calculated while the plasma concentration of morroniside was in the steady-state via intravenous drip(55 min) by LC-MS/MS. Result: Morroniside almost could not pass through the blood brain barrier in normal rats. The lg BB of morroniside in the left and right brain of focal cerebral ischemia-reperfusion model rats were(1. 36 ± 0. 44) and(2. 26 ± 0. 13),respectively,which were significantly higher than the normal control group and sham-operated group rats. Conclusion: The results demonstrated that morroniside could pass through the blood brain barrier in rats in focal cerebral ischemia-reperfusion model group more easily than normal control and sham-operated group.
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2015年第10期87-90,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家"重大新药创制"科技重大专项(2012ZX09301003-001-007)
关键词 莫诺苷 局灶性脑缺血再灌注大鼠 脑血分配系数 脑分布 morroniside focal cerebral ischemia-reperfusion model rats blood brain partitioning brain distribution
  • 相关文献

参考文献15

二级参考文献100

共引文献99

同被引文献78

  • 1赵晖,苗艳艳,苗明三.中药九蒸九晒的分析与思考[J].时珍国医国药,2018,29(11):2713-2714. 被引量:15
  • 2蔡立婧,刘家稳,李兰林,杨少林,阳剑,张啟智,彭文兴.不同剂量的胡椒碱对去甲替林在小鼠脑血分布中的影响[J].中南大学学报(医学版),2014,39(4):349-354. 被引量:2
  • 3Sachs G. Proton pump inhibitors and acid-related diseases [J]. Pharmacotherapy, 1997, 17(1): 22- 37.
  • 4Mullin JM, Gabello M, Murray LJ, ct al. Proton pump inhibitors: actions and -actions [J]. Drug Discovery Today, 2009, 14 (13/14): 648- 660.
  • 5Sachs G, Shin JM, Howden CW. Review article: the clinical pharmacology of proton pump inhibitors [J]. Aliment Pharmacol Ther, 2006, 23(Suppl 2): 2- 8.
  • 6Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics [J]. Eur J Clin Pharmacol, 2008, 64 (10): 935- 951.
  • 7Sandercock P. ' Yes' or ' no' to routine statins after subarachnoid hem- orrhage to prevent delayed cerebral ischaemia, vasospasm, and death? A cautionary tale of 2 meta- analyses[ J]. Stroke,2010,41 ( 1 ) : e1 - e2.
  • 8HAI J, DING M X. Blood - brain barrier during cerebral ischemia - reperfusion injury in inflammatory mechanisms [ J ]. Foreign Med Sci (Cerebrovasc Dis), 2001, 9(1): 15 -18.
  • 9Jung J S,Bhat R V,Preston G M,et al. Molecular characterization of an aquaporin cDNA from brain : candidate osmorecrptor and regulator of wa- ter balance[ J]. Proc Natl Acad Sci USA, 1994,91 (26) :13052 -13056.
  • 10Nielsen S, Nagelhus EA, Amiry - Moghaddam M, et al. Specialized mem- brane domains for water transport in glial cells : high - resolution immu- nogold cytochemistry of aquaporin- 4 in rat brain[ J]. Neurosci, 1997, 17(1) :171 -180.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部